It has been determined that the expression of FMNL1 is increased in many cancer types of hematopoietic origin, such as myeloid leukemia, lymphoid leukemia, and non-Hodgkin lymphoma, but its expression in solid tumors is a subject that has just begun to be studied [18,19]. Here, FMNL1 is linked to non-Hodgkin lymphoma.